92nd Annual Meeting of the North Central Section of the American Urological Association (NCSAUA)
OVERVIEW
92nd Annual Meeting of the North Central Section of the American Urological Association (NCSAUA) is organized by North Central Section of the American Urological Association (AUA), Inc. and will be held from Sep 05 - 08, 2018 at Fairmont Chicago Millennium Park, Chicago, Illinois, United States of America.
The target audience for this medical event is Urologists. This CME Conference has been approve for a maximum of 28 AMA PRA Category 1 Credits.
Conference Description :
Urologic abnormalities can present with a myriad of clinical symptoms and signs. Accurate differential diagnosis and disease management, which meets current standards of care, requires ongoing review of the presentations of various urologic abnormalities as well as the appropriate use of safe and cost-effective imaging modalities and various pharmacologic, minimally invasive, and operative management options. In addition, advancements in medical science and progress in management of various urologic diseases require basic and clinical research.
Conference Objectives are :
• Apply Evidence Based Medicine (EBM) in urologic practice specifically incorporating AUA Guidelines into daily practice.
• Explain the role of surgical management of renal/ureteral stone disease.
• Explain the evolving role of active surveillance as a treatment strategy for patients with low risk Prostate cancer (LRPC) and the use of tools such as multiparametric MRI and genomic testing for prostate cancer risk stratification.
• Describe the role of urologists in the management of castrate resistant prostate cancer.
• Analyze data pertaining to various pharmacologic and surgical treatments for voiding dysfunction and urinary incontinence.
• Utilize evidence based treatment algorithms to manage patients with challenging urolithiasis.
• Integrate new and modified treatments for erectile dysfunction, Peyronies disease, infertility, and use of testosterone.
• Explain the management of superficial and invasive bladder cancer and the associated morbidity and mortality of different methods of treatment.
• Explain coding, physician payment reforms, and collaboratives between payers and providers.
• Review the modalities of partial nephrectomy which include open, robotic laparoscopy and ablative therapies.
• Discuss the management strategies for pediatric ureteropelvic junction obstruction (UPJ) repair including robotic, laparoscopic and endoscopic techniques.
• Discuss the AUA guidelines for surgical and nonsurgical management of urinary trauma.
• Discuss surgical approaches to urethral stricture disease.
• Review and discuss unusual urologic cases.
• Identify urologic surgery complications and resolution for better outcomes.
• Describe the opioid epidemic and prescribing practices in urology.
• Outline options for treatment of Priapism.
• Describe urologic reconstruction options and outcomes.
• Discuss the future of urology.
Additional details will be posted as soon as they are available.
The target audience for this medical event is Urologists. This CME Conference has been approve for a maximum of 28 AMA PRA Category 1 Credits.
Conference Description :
Urologic abnormalities can present with a myriad of clinical symptoms and signs. Accurate differential diagnosis and disease management, which meets current standards of care, requires ongoing review of the presentations of various urologic abnormalities as well as the appropriate use of safe and cost-effective imaging modalities and various pharmacologic, minimally invasive, and operative management options. In addition, advancements in medical science and progress in management of various urologic diseases require basic and clinical research.
Conference Objectives are :
• Apply Evidence Based Medicine (EBM) in urologic practice specifically incorporating AUA Guidelines into daily practice.
• Explain the role of surgical management of renal/ureteral stone disease.
• Explain the evolving role of active surveillance as a treatment strategy for patients with low risk Prostate cancer (LRPC) and the use of tools such as multiparametric MRI and genomic testing for prostate cancer risk stratification.
• Describe the role of urologists in the management of castrate resistant prostate cancer.
• Analyze data pertaining to various pharmacologic and surgical treatments for voiding dysfunction and urinary incontinence.
• Utilize evidence based treatment algorithms to manage patients with challenging urolithiasis.
• Integrate new and modified treatments for erectile dysfunction, Peyronies disease, infertility, and use of testosterone.
• Explain the management of superficial and invasive bladder cancer and the associated morbidity and mortality of different methods of treatment.
• Explain coding, physician payment reforms, and collaboratives between payers and providers.
• Review the modalities of partial nephrectomy which include open, robotic laparoscopy and ablative therapies.
• Discuss the management strategies for pediatric ureteropelvic junction obstruction (UPJ) repair including robotic, laparoscopic and endoscopic techniques.
• Discuss the AUA guidelines for surgical and nonsurgical management of urinary trauma.
• Discuss surgical approaches to urethral stricture disease.
• Review and discuss unusual urologic cases.
• Identify urologic surgery complications and resolution for better outcomes.
• Describe the opioid epidemic and prescribing practices in urology.
• Outline options for treatment of Priapism.
• Describe urologic reconstruction options and outcomes.
• Discuss the future of urology.
Additional details will be posted as soon as they are available.
KEY DATES
05 Sep, 2018
Event Start Date
08 Sep, 2018
Event End Date
SPECIALITIES
UrologySUGGESTED HOTELS
CONFERENCE VENUE
Fairmont Chicago Millennium ParkRELATED CONFERENCES & LIVE WEBINARS
Quick Links